Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Allogene Therapeutics Inc
NASDAQ:ALLO
Allogene Therapeutics Inc
NASDAQ:ALLO
Price:
1.165
USD
-6.8%
Market Closed
Market Cap:
$402.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
Fidus Investment Corp
NASDAQ:FDUS
|
US |
|
Scully Royalty Ltd
F:MB01
|
CN |
|
A
|
Adler Group SA
F:ADJ
|
LU |
|
A
|
Arcos Dorados Holdings Inc
F:AD8
|
UY |
Wall St Price Targets
ALLO Price Forecast
Based on 11 analysts
Based on 11 analysts
+688% Upside
from
$1.165
today
Allogene Therapeutics Inc (ALLO)’s 12-month stock price forecast through October 2027 has a consensus target of $9.18, implying 688% upside. The forecast is based on price targets from 11 Wall Street analysts.
ALLO Analyst Rating
Based on 12 analysts
Based on 12 analysts
Analysts rate ALLO Strong buy, with 11 of 12 recommending Buy or Strong buy.
Allogene Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALLO's stock price target?
Price Target
9.18
USD
9.18
USD
According to Wall Street analysts, the average 1-year price target for ALLO is 9.18 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.